Lois Akinola

Ms. Lois Akinola

Virginia Commonwealth University
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2019 in Brain Sciences
Verified
Journal Article
Open access
PDF file
LALois Akinola
Lois Akinola
Bryan MckiverBryan Mckiver
Bryan Mckiver
WTWisam Toma
Wisam Toma
AZAndy Z. X. Zhu
Andy Z. X. Zhu
RTRachel F. Tyndale
Rachel F. Tyndale
MDM.Imad Damaj
M.Imad Damaj
Tobacco smoking is the major cause of disability and death in the United States and around the world. In addition, tobacco dependence and addiction express themselves as complex behaviors involving an interplay of genetics, environment, and psychological state. Mouse genetic studies could potentially elucidate the novel genes and/or gene networks regulating various aspects of nicotine dependence. Using the closely related C57BL/6 (B6) mice substrains, recent reports have noted phenotypic differences within C57BL/6J (B6J) and C57BL/6N (B6N) mice for some drugs of abuse: alcohol, opiates, and cocaine. However, the differences in nicotine’s effects have not yet been described in these substrains. We examined the phenotypic differences in these substrains following the acute and repeated administration of nicotine in several pharmacological measures, including locomotion (after acute and repeated exposure), body temperature, nociception, and anxiety-like behaviors. We report substrain differences in the pharmacological effects of acute and repeated nicotine administration in the B6 substrains. Overall, we show enhanced nicotine sensitivity to locomotion, hypothermia, antinociception, and anxiety-like behaviors in the B6J mouse substrain compared to B6N. In the repeated administration paradigm, both the B6N and B6J substrains showed no sensitized locomotor responses after repeated exposure to nicotine at the two doses tested. This study thus provides evidence that the B6 mouse substrains may be useful for genetic studies to elucidate some of the genetic variants involved in tobacco dependence and addiction.

30 May 2020 in Neuropharmacology
Verified
Journal Article
Closed access
PMPretal P. Muldoon
Pretal P. Muldoon
LALois Akinola
Lois Akinola
JSJoel E. Schlosburg
Joel E. Schlosburg
ALAron H. Lichtman
Aron H. Lichtman
LSLaura J. Sim-Selley
Laura J. Sim-Selley
MDM. Imad Damaj
M. Imad Damaj

18 January 2025 in Neuropharmacology
Verified
Journal Article
Closed access
LALois Akinola
Lois Akinola
BBBelle Buzzi
Belle Buzzi
EKErin Kalck
Erin Kalck
KLKimmie Le
Kimmie Le
SKSarah Klein
Sarah Klein
MDM. Imad Damaj
M. Imad Damaj

2 November 2022 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
LALois Akinola
Lois Akinola
YRYumna Rahman
Yumna Rahman
OOOlivia Ondo
Olivia Ondo
CCCaroline O. Cobb
Caroline O. Cobb
AHAlaina K. Holt
Alaina K. Holt
MDM. Imad Damaj
M. Imad Damaj

13 June 2022 in Frontiers in Neuroscience
Verified
Journal Article
Open access
LALois Akinola
Lois Akinola
YRYumna Rahman
Yumna Rahman
OOOlivia Ondo
Olivia Ondo
JGJada Gonzales
Jada Gonzales
DBDeniz Bagdas
Deniz Bagdas
MDM. Imad Damaj
M. Imad Damaj
Menthol has been shown to exacerbate elements of nicotine addiction in humans and rodents; however, the mechanisms mediating its effects are not fully understood. This study examined the impact of genetic factors in menthol’s effects on oral nicotine consumption by comparing two inbred mouse strains with differing sensitivities to nicotine. C57BL/6J (B6J) mice are nicotine-preferring, while DBA/2J (D2J) mice are not. While the effects of menthol on oral nicotine consumption have been highlighted in B6J mice, it is unknown if they extend to the D2J strain as well. Consequently, adolescent (PND 21) and adult (PND 63), male and female D2J mice were subjected to the nicotine two-bottle choice (2BC) paradigm with orally and systemically administered menthol. Then, we evaluated its impact on nicotine pharmacological responses in conditioned reward and nociception after systemic administration and, lastly, investigated the potential involvement of the TAAR1 gene and α7 nAChRs in menthol’s effects. Menthol failed to enhance oral nicotine consumption in adult and adolescent female and male D2J mice. Moreover, this lack in effect was not due to nicotine concentration, oral aversion to menthol, or basal preference for nicotine. Menthol also failed to augment nicotine reward or enhance nicotine-induced antinociception in D2J mice, demonstrating that genetic background plays a significant role in sensitivity to menthol’s effects on nicotine. Furthermore, TAAR1 or α7 nAChRs did not seem to mediate menthol’s differential effects in D2J mice. These findings support the existence of genotype-specific mechanisms that may contribute to the variable effects of menthol in different populations.

25 June 2020 in Molecules
Verified
Journal Article
Open access
PDF file
FDFarah Deba
Farah Deba
KRKara Ramos
Kara Ramos
MVMatthew Vannoy
Matthew Vannoy
KMKemburli Munoz
Kemburli Munoz
LALois Akinola
Lois Akinola
AHAyman K Hamouda
Ayman K Hamouda
Neuronal nicotinic acetylcholine receptor (nAChR)-based therapeutics are sought as a potential alternative strategy to opioids for pain management. In this study, we examine the antinociceptive effects of 3-(2-chlorophenyl)-5-(5-methyl-1-(piperidin-4-yl)-1H-pyrazol-4-yl)isoxazole (CMPI), a novel positive allosteric modulator (PAM), with preferential selectivity to the low agonist sensitivity (α4)3(β2)2 nAChR and desformylflustrabromine (dFBr), a PAM for α4-containing nAChRs. We used hot plate and tail flick tests to measure the effect of dFBr and CMPI on the latency to acute thermal nociceptive responses in rats. Intraperitoneal injection of dFBr, but not CMPI, dose-dependently increased latency in the hot plate test. In the tail flick test, the effect achieved at the highest dFBr or CMPI dose tested was only <20% of the maximum possible effects reported for nicotine and other nicotinic agonists. Moreover, the coadministration of dFBr did not enhance the antinociceptive effect of a low dose of nicotine. Our results show that the direct acute effect of dFBr is superior to that for CMPI, indicating that selectivity to (α4)3(β2)2 nAChR is not advantageous in alleviating responses to acute thermal nociceptive stimulus. However, further studies are necessary to test the suitability of (α4)3(β2)2 nAChR-selective PAMs in chronic pain models.